Company Filing History:
2 out of 45 
1 out of 453 
1 out of 13 Years Active: 2014-2015
Title: Innovations by Mercedes Unzeta López
Introduction
Mercedes Unzeta López is a notable inventor based in Barcelona, Spain. She has made significant contributions to the field of neuroprotective compounds and methods for treating hemorrhagic disorders. With a total of two patents to her name, her work is focused on addressing critical health issues such as Alzheimer's and Parkinson's diseases.
Latest Patents
One of her latest patents involves derivatives of propargylamine that possess neuroprotective capacity for the treatment of Alzheimer's and Parkinson's diseases. This invention relates to a compound of a specific formula, which includes various chemical groups that enhance its therapeutic potential. The patent outlines the procedure for obtaining these compounds, their pharmaceutical compositions, and their application in treating neurodegenerative diseases.
Another significant patent by López provides methods and compositions for the treatment and diagnosis of hemorrhagic conversion. This invention includes a method for predicting hemorrhagic disorders by determining amine oxidase levels in patient samples. It also encompasses pharmaceutical compositions that combine an inhibitor of amine oxidase with an antithrombotic agent, aimed at treating hemorrhagic disorders effectively.
Career Highlights
Mercedes has worked with prestigious institutions such as Universitat Autonoma de Barcelona and Consejo Superior de Investigaciones Científicas. Her research and innovations have contributed to advancements in medical science, particularly in neurodegenerative diseases and hemorrhagic conditions.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Abdelouahid Samadi and José Luis Marco Contelles. These partnerships have further enriched her research and development efforts.
Conclusion
Mercedes Unzeta López is a pioneering inventor whose work has the potential to significantly impact the treatment of neurodegenerative diseases and hemorrhagic disorders. Her contributions to science and medicine are commendable and reflect her dedication to improving health outcomes.